Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Meropol

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Oral fluoropyrimidines in the treatment of colorectal cancerN J Meropol
Oncology (Williston Park, N.Y.)|July 11, 2000
Oral therapy for colorectal cancer: how to chooseN Damjanov, N J Meropol
Cancer Investigation|December 7, 2000
Oral fluoropyrimidines in cancer treatmentN L Lewis, N J Meropol
Seminars in Oncology|December 1, 1992
The current status of toxicity protectants in cancer therapyL M Schuchter, W E Luginbuhl, N J Meropol
Oncology (Williston Park, N.Y.)|December 1, 1992
High-dose chemotherapy with autologous stem cell support for breast cancerN J Meropol, B A Overmoyer, E A Stadtmauer
Perspectives in Biology and Medicine|January 1, 1985
Factitious illness: an exploration in ethicsN J Meropol, C V Ford, R M Zaner
American Journal of Clinical Oncology|April 16, 1998
Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorinN J Meropol, L E Blumenson, P J Creaven
Current Opinion in Oncology|June 29, 2001
Chemoprevention of colorectal cancerM L Clapper, W C Chang, N J Meropol
Antimicrobial Agents and Chemotherapy|March 1, 1981
Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporinH C Neu, N J Meropol, K P Fu
Seminars in Oncology|October 1, 1995
Metastatic colorectal cancer: advances in biochemical modulation and new drug developmentN J Meropol, P J Creaven, N J Petrelli
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Oral fluoropyrimidines in the treatment of colorectal cancerN J Meropol
Oncology (Williston Park, N.Y.)|July 11, 2000
Oral therapy for colorectal cancer: how to chooseN Damjanov, N J Meropol
Cancer Investigation|December 7, 2000
Oral fluoropyrimidines in cancer treatmentN L Lewis, N J Meropol
Seminars in Oncology|December 1, 1992
The current status of toxicity protectants in cancer therapyL M Schuchter, W E Luginbuhl, N J Meropol
Oncology (Williston Park, N.Y.)|December 1, 1992
High-dose chemotherapy with autologous stem cell support for breast cancerN J Meropol, B A Overmoyer, E A Stadtmauer
Perspectives in Biology and Medicine|January 1, 1985
Factitious illness: an exploration in ethicsN J Meropol, C V Ford, R M Zaner
American Journal of Clinical Oncology|April 16, 1998
Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorinN J Meropol, L E Blumenson, P J Creaven
Current Opinion in Oncology|June 29, 2001
Chemoprevention of colorectal cancerM L Clapper, W C Chang, N J Meropol
Antimicrobial Agents and Chemotherapy|March 1, 1981
Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporinH C Neu, N J Meropol, K P Fu
Seminars in Oncology|October 1, 1995
Metastatic colorectal cancer: advances in biochemical modulation and new drug developmentN J Meropol, P J Creaven, N J Petrelli
Pageof 7